Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities

publication date: Jan 23, 2023
 | 
author/source: Metrion Biosciences

metrion-biosciences-invests-new-high-throughput

 

Expanded facilities gives Company total of 20,160 sq. ft at Granta Park, Cambridge, UK

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, announce the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.

The Company has signed a nine-year lease for an additional 8,160 sq. ft of space adjacent to its headquarters on Granta Park, Cambridge, UK, giving a combined total of 20,000 sq. ft (1,860 m2). The new facility and HTS capabilities, which include 384 well screening via FLIPR Penta and Qube-384, will provide significant additional capacity and flexibility to serve ongoing and future ion channel drug discovery projects for Metrion’s global client base. The Company has also installed an Agilent Bravo liquid handling robot, adding further capacity to its suite of automated sample preparation and compound handling instruments.

Scott Maidment has been appointed as Head of HTS to lead the introduction of the new service. Scott joins Metrion from Charles River Laboratories, where he was Senior Research Leader. He has almost 30 years’ experience of bioscience laboratory work, including over 20 years in drug discovery contract research for global clients. Scott has extensive expertise in ion channel research gained through multiple HTS campaigns, screening support services, and integrated medicinal chemistry projects targeting transient receptor potential (TRP), two pore domain, calcium-activated K+, ligand- and voltage-gated channel families.

“Following significant growth in Metrion’s global business in 2022, particularly within the USA, the newly acquired space will ensure our ambitious plan for global commercial expansion continues to gather momentum,” said Dr Andrew Southan, Chief Executive of Metrion Biosciences. “The launch of our HTS capability adds another layer of depth to our ion channel drug discovery services and complements our automated and conventional electrophysiology services. Having personally worked with Scott on multiple drug discovery projects prior to joining the Metrion team, I have total confidence in his abilities as a HTS specialist to deliver first class screening services to our clients.”

Scott Maidment, Head of High Throughput Screening at Metrion Biosciences, added: “Metrion sits at the forefront of the ion channel drug discovery industry as a research provider, and I am delighted to be joining the team at such an exciting phase of its commercial growth as it continues to strengthen its position on the global stage. I look forward to leading the new HTS capability, which will be invaluable to both new and existing client projects.”

 

Video - Metrion Biosciences laboratory tour

 

 

About Metrion Biosciences

Metrion Biosciences is a specialist ion-channel contract research organization and drug discovery business. The Company provides customers with access to a range of high-quality ion channel assays on a fee-for-service or collaboration basis. Metrion Biosciences’ ion channel expertise includes an industry leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Metrion Biosciences is able to provide tailored assay formats, data analysis and reporting solutions, effective project management and quality assured data packages.

 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events